Mirum Pharmaceuticals, Inc. Common Stock

MIRMNASDAQ • USD
93.51 USD
↘ 0.49 (0.52%)🟢LIVE (AS OF 12:08 PM EST)
🟢Market: OPEN

MIRM is currently priced at $93.51. MIRM shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (1668.1%) and a bearish Death Cross on the long-term moving averages. On the valuation front, MIRM trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 13, 2026.

Open?$92.28
High?$94.54
Low?$91.07
Prev. Close?$93.99
Volume?168.2K
Avg. Volume?705.5K
VWAP?$92.70
Rel. Volume?0.24x
Bid / Ask
Bid?$93.30 × 100
Ask?$94.12 × 100
Spread?$0.82
Midpoint?$93.71
Valuation & Ratios
Market Cap?6.1B
Shares Out?65.3M
Float?51.7M
Float %?79.6%
P/E Ratio?N/A
P/B Ratio?-113.24
EPS?-$13.85
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Employees
433
Market Cap
6.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-07-18
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404
Phone: 650-667-4085
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
1
Momentum?
73
Short Sent.?
28
Piotroski F-Score?2/9Weak
Altman Z-Score?-0.60Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?12.62%High
Short Interest?6.5M
Days to Cover?11.8
Free Float51.7M
Avg Daily Volume551.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.07Strong
Quick Ratio?1.98Adequate
Cash Ratio?0.86Adequate
Debt/Equity?-13.50Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-113.24CHEAP▾
P/S?
Peers
100
S&P
9
9.15HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.6CHEAP▾
EV/Sales?
Peers
100
S&P
11
9.87HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
1,668.1%STRONG▾
ROA?
S&P
3
-88.0%WEAK▾
Cash Flow & Enterprise
FCF?$-273851000
Enterprise Value?$6.6B
Fundamentals ratios updated end of day